Sight diagnostics: Artificial Intelligence solution to help prevent blindness

By: |
March 15, 2021 3:15 AM

Intel-powered AI solution Netra.AI helps reduce diabetic vision loss

Research shows that DR is a leading cause of blindness and vision loss in adults, and early detection and treatment is critical to stopping the damage.Research shows that DR is a leading cause of blindness and vision loss in adults, and early detection and treatment is critical to stopping the damage.

Sankara Eye Foundation and Singapore-based Leben Care are deploying a comprehensive retina risk assessment software-as-a-service platform in India. Netra.AI, the cloud-based artificial intelligence (AI) solution, is powered by Intel technology and uses deep learning to identify retinal conditions in a short span of time with the accuracy level of human doctors. Netra.AI can identify diabetic retinopathy (DR), reducing the screening burden on vitreoretinal surgeons.

“India has one of the largest diabetic populations in the world and diabetic retinopathy is the major cause for vision loss and blindness in persons of working age. With Netra.AI, Sankara Eye Foundation and Leben Care have leveraged the power of Intel Xeon Scalable processors and built-in Intel Deep Learning (DL) Boost to accurately detect DR and enable timely treatment to effectively combat avoidable vision impairment and blindness in diabetic patients,” said Prakash Mallya, VP & MD of Sales, Marketing and Communications Group, Intel India.

Why it matters: Research shows that DR is a leading cause of blindness and vision loss in adults, and early detection and treatment is critical to stopping the damage. However, the lack of trained retinal specialists in India—especially in remote, rural regions—limits effective screening of asymptomatic patients. This results in patients presenting late with advanced diabetic eye disease.

Netra.AI analyses images from portable, technician-operated fundus camera devices, for immediate results of referable DR grading via a cloud-based web portal. The solution uses cutting-edge AI algorithms, developed in collaboration with leading retina experts, with a four-step deep convolutional neural network (DCNN). This neural network helps in detecting DR stage and annotating lesions based on pixel density in the fundus images. The solution can be expanded to other retinal conditions and glaucoma, helping to reduce the screening burden on healthcare specialists and focus key resources on patients who need immediate care and intervention.

So far, Netra.AI has screened 3,093 patients in India and identified 742 at-risk patients. The solution generates detailed reports within two minutes of uploading images and offers immediate and highly accurate diagnosis to help doctors provide instant counsel for patients needing a referral to the hospital.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Not kidding, someone built a tiny washing machine to clean your wax-encrusted AirPods
2BSNL extends popular Rs 398 prepaid plan for another 90 days, here are the all the benefits
3DuckDuckGo is asking users to ditch Google Chrome, here’s why